These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 32988769)
21. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China]. Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers. Alzahrani FM; Muzaheed ; Shaikh SS; Alomar AI; Acharya S; Elhadi N Ann Lab Med; 2019 Jan; 39(1):81-85. PubMed ID: 30215234 [TBL] [Abstract][Full Text] [Related]
23. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. Ringelhan M; O'Connor T; Protzer U; Heikenwalder M J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558 [TBL] [Abstract][Full Text] [Related]
24. Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer. Chang MH; You SL; Chen CJ; Liu CJ; Lai MW; Wu TC; Wu SF; Lee CM; Yang SS; Chu HC; Wang TE; Chen BW; Chuang WL; Soon MS; Lin CY; Chiou ST; Kuo HS; Chen DS; Gastroenterology; 2016 Sep; 151(3):472-480.e1. PubMed ID: 27269245 [TBL] [Abstract][Full Text] [Related]
25. Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation. Zhang L; Tao Y; Woodring J; Rattana K; Sovannarith S; Rathavy T; Cheang K; Hossain S; Ferradini L; Deng S; Sokun C; Samnang C; Nagai M; Lo YR; Ishikawa N Int J Epidemiol; 2019 Aug; 48(4):1327-1339. PubMed ID: 30879066 [TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant. Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165 [TBL] [Abstract][Full Text] [Related]
28. Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. Madani TA Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):278-83. PubMed ID: 16600318 [TBL] [Abstract][Full Text] [Related]
29. Perspectives and control of hepatitis B virus infection in Taiwan. Lin CL; Kao JH J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection. Aljumah AA; Kuriry H; Faisal N; Alghamdi H Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991 [TBL] [Abstract][Full Text] [Related]
31. Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union. Pereira A Transfusion; 2003 Feb; 43(2):192-201. PubMed ID: 12559015 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of treating all hepatitis B-positive individuals in the United States. Razavi-Shearer D; Estes C; Gamkrelidze I; Razavi H J Viral Hepat; 2023 Sep; 30(9):718-726. PubMed ID: 37260095 [TBL] [Abstract][Full Text] [Related]
33. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217 [TBL] [Abstract][Full Text] [Related]
34. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109 [TBL] [Abstract][Full Text] [Related]
35. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690 [TBL] [Abstract][Full Text] [Related]
36. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China. Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Kao JH Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252 [TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of universal newborn hepatitis B vaccination in China. Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752 [TBL] [Abstract][Full Text] [Related]
39. Risk stratification for hepatitis B virus related hepatocellular carcinoma. Lin CL; Kao JH J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699 [TBL] [Abstract][Full Text] [Related]
40. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study. Park YM; Lee SG World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]